267 related articles for article (PubMed ID: 34016257)
1. Survival After Implantable Cardioverter-Defibrillator Shocks.
Aktaş MK; Younis A; Zareba W; Kutyifa V; Klein H; Daubert JP; Estes M; McNitt S; Polonsky B; Goldenberg I
J Am Coll Cardiol; 2021 May; 77(20):2453-2462. PubMed ID: 34016257
[TBL] [Abstract][Full Text] [Related]
2. QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients.
Goldenberg I; Aktas MK; Zareba W; Tsu-Chau Huang D; Rosero SZ; Younis A; McNitt S; Stockburger M; Steinberg JS; Buttar RS; Merkely B; Kutyifa V
JACC Clin Electrophysiol; 2024 Jan; 10(1):16-26. PubMed ID: 38032575
[TBL] [Abstract][Full Text] [Related]
3. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Importance of Defibrillator-Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure.
Biton Y; Daimee UA; Baman JR; Kutyifa V; McNitt S; Polonsky B; Zareba W; Goldenberg I
J Am Heart Assoc; 2019 Mar; 8(6):e010346. PubMed ID: 30857452
[TBL] [Abstract][Full Text] [Related]
6. Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT.
Schuger C; Daubert JP; Zareba W; Rosero S; Yong P; McNitt S; Kutyifa V
Heart Rhythm; 2021 Mar; 18(3):399-403. PubMed ID: 33232811
[TBL] [Abstract][Full Text] [Related]
7. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.
Sood N; Ruwald AC; Solomon S; Daubert JP; McNitt S; Polonsky B; Jons C; Clyne CA; Zareba W; Moss AJ
Eur Heart J; 2014 Jan; 35(2):106-15. PubMed ID: 24179073
[TBL] [Abstract][Full Text] [Related]
8. Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy.
Perini AP; Kutyifa V; Veazie P; Daubert JP; Schuger C; Zareba W; McNitt S; Rosero S; Tompkins C; Padeletti L; Moss AJ
Am Heart J; 2017 Jul; 189():75-84. PubMed ID: 28625384
[TBL] [Abstract][Full Text] [Related]
9. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
[TBL] [Abstract][Full Text] [Related]
10. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
11. Association of device detected atrial and ventricular tachyarrhythmia with adverse events in patients with an implantable cardioverter-defibrillator.
Abbas H; Younis A; Goldenberg I; McNitt S; Aktas MK; Tabaja C; Ojo A
J Cardiovasc Electrophysiol; 2024 Jun; 35(6):1203-1211. PubMed ID: 38606650
[TBL] [Abstract][Full Text] [Related]
12. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
Klein RC; Raitt MH; Wilkoff BL; Beckman KJ; Coromilas J; Wyse DG; Friedman PL; Martins JB; Epstein AE; Hallstrom AP; Ledingham RB; Belco KM; Greene HL;
J Cardiovasc Electrophysiol; 2003 Sep; 14(9):940-8. PubMed ID: 12950538
[TBL] [Abstract][Full Text] [Related]
13. Effect of Carvedilol vs Metoprolol on Atrial and Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients.
Diamond A; Goldenberg I; Younis A; Goldenberg I; Sampath R; Kutyifa V; Chen AY; McNitt S; Polonsky B; Steinberg JS; Zareba W; Aktaş MK
JACC Clin Electrophysiol; 2023 Oct; 9(10):2122-2131. PubMed ID: 37656097
[TBL] [Abstract][Full Text] [Related]
14. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.
Sweeney MO; Sherfesee L; DeGroot PJ; Wathen MS; Wilkoff BL
Heart Rhythm; 2010 Mar; 7(3):353-60. PubMed ID: 20185109
[TBL] [Abstract][Full Text] [Related]
15. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score.
Younis A; Goldberger JJ; Kutyifa V; Zareba W; Polonsky B; Klein H; Aktas MK; Huang D; Daubert J; Estes M; Cannom D; McNitt S; Stein K; Goldenberg I
Eur Heart J; 2021 May; 42(17):1676-1684. PubMed ID: 33417692
[TBL] [Abstract][Full Text] [Related]
16. Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator.
Aktaş MK; Younis A; Saxena S; Diamond A; Ojo A; Kutyifa V; Steiner H; Steinberg JS; Zareba W; McNitt S; Polonsky B; Rosero SZ; Huang DT; Goldenberg I
JACC Clin Electrophysiol; 2023 Jul; 9(7 Pt 1):979-988. PubMed ID: 36752470
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?
Russo AM; Nayak H; Verdino R; Springman J; Gerstenfeld E; Hsia H; Marchlinski FE
Pacing Clin Electrophysiol; 2003 Dec; 26(12):2289-95. PubMed ID: 14675014
[TBL] [Abstract][Full Text] [Related]
18. Sex-Related Differences in Ventricular Tachyarrhythmia Events in Patients With Implantable Cardioverter-Defibrillator and Prior Ventricular Tachyarrhythmias.
Krzowski B; Kutyifa V; Vloka M; Huang DT; Attari M; Aktas M; Shah AH; Musat D; Rosenthal L; McNitt S; Polonsky B; Schuger C; Natale A; Ziv O; Beck C; Daubert JP; Goldenberg I; Zareba W
JACC Clin Electrophysiol; 2024 Feb; 10(2):284-294. PubMed ID: 38032582
[TBL] [Abstract][Full Text] [Related]
19. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
[TBL] [Abstract][Full Text] [Related]
20. Sex Differences in Inappropriate ICD Device Therapies: MADIT-II and MADIT-CRT.
Tompkins CM; McNitt S; Polonsky B; Daubert JP; Wang PJ; Moss AJ; Zareba W; Kutyifa V
J Cardiovasc Electrophysiol; 2017 Jan; 28(1):94-102. PubMed ID: 27696593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
